A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
Scientists have been trying for a long time to deliver vaccines without needles. Now the Boston biotech community is importing a new take on this idea from Australia that’s also caught the eye of Merck. Xconomy